Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2016 3
2017 1
2019 5
2020 7
2021 3
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Identification of an endogenous retroviral signature to predict anti-PD1 response in advanced clear cell renal cell carcinoma: an integrated analysis of three clinical trials.
Zhou JG, Zeng Y, Wang H, Jin SH, Wang YJ, He S, Frey B, Fietkau R, Hecht M, Ma H, Zhang W, Gaipl US. Zhou JG, et al. Among authors: jin sh. Ther Adv Med Oncol. 2022 Sep 24;14:17588359221126154. doi: 10.1177/17588359221126154. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 37614979 Free PMC article.
Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients - Knowledge from two independent international studies.
Zhou JG, Liang R, Wang HT, Jin SH, Hu W, Frey B, Fietkau R, Hecht M, Ma H, Gaipl US. Zhou JG, et al. Among authors: jin sh. Neoplasia. 2023 Mar;37:100877. doi: 10.1016/j.neo.2023.100877. Epub 2023 Jan 23. Neoplasia. 2023. PMID: 36696838 Free PMC article.
Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials.
Zhou JG, Wong AH, Wang H, Jin SH, Tan F, Chen YZ, He SS, Shen G, Frey B, Fietkau R, Hecht M, Carr SR, Wang R, Shen B, Schrump DS, Ma H, Gaipl US. Zhou JG, et al. Among authors: jin sh. Front Immunol. 2022 Sep 2;13:961926. doi: 10.3389/fimmu.2022.961926. eCollection 2022. Front Immunol. 2022. PMID: 36119066 Free PMC article.
Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods.
Zhou JG, Wong AH, Wang H, Tan F, Chen X, Jin SH, He SS, Shen G, Wang YJ, Frey B, Fietkau R, Hecht M, Ma H, Gaipl US. Zhou JG, et al. Among authors: jin sh. Front Immunol. 2022 Jun 30;13:862752. doi: 10.3389/fimmu.2022.862752. eCollection 2022. Front Immunol. 2022. PMID: 35844547 Free PMC article.
23 results